Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1997-10-03
1999-11-09
Krass, Frederick
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
5142315, 5142358, 5142365, 5142372, 514383, A61K 31535
Patent
active
059815264
ABSTRACT:
The present invention relates to a method for the treatment or prevention of migraine, which method comprises administration to a patient in need of such treatment an amount of a tachykinin antagonist and an amount of rizatriptan such that together they give effective relief. There is also provided pharmaceutical compositions and products comprising a tachykinin antagonist and rizatriptan.
REFERENCES:
patent: 5451588 (1995-09-01), Baker et al.
patent: 5719147 (1998-02-01), Dorn et al.
patent: 5744482 (1998-04-01), Cohen et al.
Krass Frederick
Merck Sharp & Dohme Ltd.
Rose David L.
Thies J. Eric
LandOfFree
Use of tachykinin antagonist and rizatriptan does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of tachykinin antagonist and rizatriptan, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of tachykinin antagonist and rizatriptan will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1456214